ANTHEM-HFrEF Pivotal Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 533 participants.
Also called NCT03425422
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 533 participants
- Sponsor
- Registry
-
NCT03425422
-
- Other papers using this trial's data
- Vagal Nerve Stimulation in Patients With Heart Failure and Reduced Ejection Fraction: The ANTHEM-HFrEF Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT03425422. Randomized; no masking; primary purpose treatment. Start 2018-05-01 (actual); primary completion 2023-05-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ANTHEM-HFrEF Pivotal Study
- Condition
- Heart Failure
- Condition
- Heart Failure, Congestive
- Condition
- Heart Failure, Systolic
- Intervention (Device)
- VITARIA System
- Lead sponsor
- LivaNova
Record details
- Record id
cardio:ct-nct03425422- Content hash
084619340b34d4eb271ff47a1cc11fd9e5bc614a42cd06a89c101fbf8f4a8c72